Computerized Neuropsychological Assessment Devices: Joint Position Paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology
| Autor: | Alison Cernich, Laurence M. Binder, Ronald M. Ruff, Richard I. Naugle, Russell M. Bauer, Grant L. Iverson |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Psychometrics
Applied psychology Data security Test validity Neuropsychological Tests Article Cognition Arts and Humanities (miscellaneous) Neuropsychology Health care Developmental and Educational Psychology medicine Humans Diagnosis Computer-Assisted Neuropsychological assessment medicine.diagnostic_test Computers business.industry Reproducibility of Results General Medicine United States Test (assessment) Psychiatry and Mental health Clinical Psychology Clinical neuropsychology Neuropsychology and Physiological Psychology Commentary Position paper Psychology business Neurocognitive Social psychology |
| Zdroj: | Archives of Clinical Neuropsychology. 27:362-373 |
| ISSN: | 1873-5843 0887-6177 |
| Popis: | This joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology sets forth our position on appropriate standards and conventions for computerized neuropsychological assessment devices (CNADs). In this paper, we first define CNADs and distinguish them from examiner-administered neuropsychological instruments. We then set forth position statements on eight key issues relevant to the development and use of CNADs in the healthcare setting. These statements address (a) device marketing and performance claims made by developers of CNADs; (b) issues involved in appropriate end-users for administration and interpretation of CNADs; (c) technical (hardware/software/firmware) issues; (d) privacy, data security, identity verification, and testing environment; (e) psychometric development issues, especially reliability, and validity; (f) cultural, experiential, and disability factors affecting examinee interaction with CNADs; (g) use of computerized testing and reporting services; and (h) the need for checks on response validity and effort in the CNAD environment. This paper is intended to provide guidance for test developers and users of CNADs that will promote accurate and appropriate use of computerized tests in a way that maximizes clinical utility and minimizes risks of misuse. The positions taken in this paper are put forth with an eye toward balancing the need to make validated CNADs accessible to otherwise underserved patients with the need to ensure that such tests are developed and utilized competently, appropriately, and with due concern for patient welfare and quality of care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|